Search Results 341-350 of 2997 for 搜索引擎入口咨询邮箱：lgooxc@hotmail.com

1. Transplant Organ Genomics to Help Prevent Rejection in Kidney Transplant Recipients – RNA-seq Signature Validation - Mayo Clinic

   About this study. The purpose of this study is to validate the use of an RNA-seq based peripheral blood assay in renal transplant recipients in adult kidney ...

2. Collaborators - Pharmacogenomics - Mayo Clinic Research

   Collaborators. Dr. Weinshilboum is involved in various research collaborations within Mayo Clinic. Mayo Clinic collaborators. Joanna M. Biernacka, Ph.D.

3. Response-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome - Mayo Clinic

   Response-based treatment may be effective in treating acute myeloid leukemia or myelodysplastic syndrome in younger patients with Down syndrome while reducing ...

4. Research Registration Application - Center for Clinical and Translational Science

   The Research Registration Application is a Mayo Clinic-designed app supporting Mayo's role as a registration and randomization center for clinical trials. It ...

5. Faculty - Center for Individualized Medicine - Mayo Clinic Research

   Robinson, Steven I. M.B.B.S.. Robinson.Steven@mayo.edu; Associate Professor of Oncology. More about research at Mayo Clinic.

6. Training Opportunities - Human Immunodeficiency Virus Lab: Andrew D. Badley - Mayo Clinic Research

   Mayo Clinic offers several education programs for aspiring researchers.

7. Safety and Tolerability Study of SNS01-T in Relapsed or Refractory B Cell Malignancies (Multiple Myeloma, B Cell Lymphoma, or Plasma Cell Leukemia (PCL) - Mayo Clinic

   The purpose of this study is to determine how well SNS01-T is tolerated by relapsed or refractory multiple myeloma, B cell lymphoma or plasma cell leukemia ...

8. Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab (DeLLphi-305) - Mayo Clinic

   Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide ...

9. Department of Defense Medical Research Office - Overview

   Learn how this innovative research and business-to-business collaboration is developing novel medical treatments and solutions for the military.

10. Benefits - Center for Clinical and Translational Science

    The CCaTS Office of Translation to Practice offers multiple benefits to Mayo Clinic individual researchers and collaborators.